Interleukin-2 Receptor alpha Subunit
"Interleukin-2 Receptor alpha Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low affinity interleukin-2 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-2.
| Descriptor ID |
D053645
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.320.500
|
| Concept/Terms |
Interleukin-2 Receptor alpha Subunit- Interleukin-2 Receptor alpha Subunit
- Interleukin 2 Receptor alpha Subunit
- Antigens, CD25
- CD25 Antigens
- Tac P55 Peptide
- Interleukin-2 Receptor alpha
- Interleukin 2 Receptor alpha
- Receptor alpha, Interleukin-2
- Interleukin-2 Receptor alpha Chain
- Interleukin 2 Receptor alpha Chain
- Interleukin-2 Receptors alpha
- Interleukin 2 Receptors alpha
- Receptors alpha, Interleukin-2
- IL-2Ralpha
- IL 2Ralpha
- Interleukin-2Ralpha
- Interleukin 2Ralpha
- CD25 Antigen
- Antigen, CD25
- alpha-subunit, Receptor, Interleukin-2
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-2 Receptor alpha Subunit".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-2 Receptor alpha Subunit".
This graph shows the total number of publications written about "Interleukin-2 Receptor alpha Subunit" by people in this website by year, and whether "Interleukin-2 Receptor alpha Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 3 | 3 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-2 Receptor alpha Subunit" by people in Profiles.
-
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. BMC Neurol. 2016 Jul 26; 16:117.
-
An Arthritis-Suppressive and Treg Cell-Inducing CD4+ T Cell Epitope Is Functional in the Context of HLA-Restricted T Cell Responses. Arthritis Rheumatol. 2016 Mar; 68(3):639-47.
-
Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol. 2013 Jan; 8(1):31-6.
-
Functional defect in regulatory T cells in myasthenia gravis. Ann N Y Acad Sci. 2012 Dec; 1274:68-76.
-
Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis. Clin Immunol. 2012 Dec; 145(3):209-23.
-
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. PLoS One. 2012; 7(2):e32165.
-
Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J Autoimmun. 2011 Mar; 36(2):142-54.
-
A pilot study of denileukin diftitox (DD) in combination with high-dose interleukin-2 (IL-2) for patients with metastatic renal cell carcinoma (RCC). J Immunother. 2010 Sep; 33(7):716-22.
-
Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol. 2009 Aug 01; 183(3):2045-58.